May 1, 2010

Slouching towards Bethlehem: the beast of biocompatibility

.   .   

This editorial by Dr. Joanne Bargman provides a critical analysis of the study “Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study”.

Related Articles:

Peritoneal Dialysis

Comments are closed.